StockTipsArenaBeta

BUY Orchid Pharma Limited — Rajesh Satpute

BUYOrchid Pharma Limited
Orchid Pharma share price target & all analyst calls

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))9 Sept 2026via CNBC Awaaz.

Entry₹1,025.8Inferred
Target₹1,060
Total upside +3.33% (call closed)
Stop loss₹1,010-1.54% risk
Exit₹1,01010 Sept 2026, 10:00 am
Stop-loss hit-1.54%
Follow Rajesh Satpute for new calls(32% target hit, 201 closed calls)Get alertsWatch ORCHPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Sept 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Neutral / worth noting (1)

Orchid Pharma Limited's Board Meeting on Sep 03, 2026, approved the appointment of Cost Auditors for FY 2026-27 and Mr. Arjun Dhanuka as Whole-Time Director. The meeting also set dates for the 33rd AG

NSE · Outcome of Board Meeting·3 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Orchid Pharma

All analyst calls on Orchid Pharma

More from Rajesh Satpute

Every call and its outcome